Hyderabad: Suven Life Sciences has announced that the first patient has been randomized in its Phase-2b clinical trial ...

More than 7 million people in the United States live with Alzheimer's disease and related dementia (ADRD). Some risk factors ...

Suven Life Sciences announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a novel oral α4β2 nicotinic acetylcholine receptor (nAChR) antagonist, ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Mothers experiencing depression have considerable challenges across multiple parenting domains, according to a global ...

Emotional and peer-related problems in early childhood were strongly linked to a higher risk of adult depression among those ...

A novel @HopkinsKids study adds to evidence that a liver-damaging virus is linked to some psychiatric disorders. › ...

Earlier identification is also of interest due to the possibility that earlier intervention may be more effective with more ...

Of the 16 available MDD prediction instruments, researchers recommend using those assessing prior treatments and clinical characteristics.